THE DEVELOPMENT OF UROKINASE AS A THROMBOLYTIC AGENT. MAINTENANCE OF A SUSTAINED THROMBOLYTIC STATE IN MAN BY ITS INTRAVENOUS INFUSION.
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- May 1965
has subject area
- 1103 Clinical Sciences (FoR)
- Angiography (MeSH)
- Deoxyribonuclease I (MeSH)
- Drug Therapy (MeSH)
- Fibrinolysis (MeSH)
- Fibrinolytic Agents (MeSH)
- General Clinical Medicine (Science Metrix)
- Geriatrics (MeSH)
- Infusions, Intravenous (MeSH)
- Infusions, Parenteral (MeSH)
- Streptodornase and Streptokinase (MeSH)
- Streptokinase (MeSH)
- Thrombophlebitis (MeSH)
- Thromboplastin (MeSH)
- Thrombosis (MeSH)
- Urokinase-Type Plasminogen Activator (MeSH)
published in
- Translational Research Journal